Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05934032Recruiting

National Network Genomic Medicine Lung Cancer, Germany

Role: collaborator

NCT04669522Unknown

Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer

Role: lead

NCT02847676Unknown

Differences in Peritoneal Stem Cells in Women With and Without Adhesions After Gynaecological Surgery

Role: lead

NCT02165917Phase 4Unknown

Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier

Role: lead

All 4 trials loaded